187 related articles for article (PubMed ID: 23307253)
21. Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
Yildirim N; Akman L; Acar K; Demir S; Ozkan S; Alan N; Zekioglu O; Terek MC; Ozdemir N; Ozsaran A
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():55-61. PubMed ID: 28601728
[TBL] [Abstract][Full Text] [Related]
22. [The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].
Xia R; Wang F; Gao T; Wen W; Lu B; Zhu Y; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):740-3. PubMed ID: 25001941
[TBL] [Abstract][Full Text] [Related]
23. Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer.
Dai C; Geng R; Wang C; Wong A; Qing M; Hu J; Sun Y; Lo AW; Li J
Mol Oncol; 2016 Dec; 10(10):1551-1558. PubMed ID: 27720576
[TBL] [Abstract][Full Text] [Related]
24. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma.
Cunha LL; Morari EC; Guihen AC; Razolli D; Gerhard R; Nonogaki S; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2012 Dec; 77(6):918-25. PubMed ID: 22738343
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
26. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
[TBL] [Abstract][Full Text] [Related]
27. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
Sugasawa H; Ichikura T; Kinoshita M; Ono S; Majima T; Tsujimoto H; Chochi K; Hiroi S; Takayama E; Saitoh D; Seki S; Mochizuki H
Int J Cancer; 2008 Jun; 122(11):2535-41. PubMed ID: 18246596
[TBL] [Abstract][Full Text] [Related]
28. Decreased density of CD3+ tumor-infiltrating lymphocytes during gastric cancer progression.
Arigami T; Uenosono Y; Ishigami S; Matsushita D; Hirahara T; Yanagita S; Okumura H; Uchikado Y; Nakajo A; Kijima Y; Natsugoe S
J Gastroenterol Hepatol; 2014; 29(7):1435-41. PubMed ID: 25587614
[No Abstract] [Full Text] [Related]
29. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
Zhao KL; Liu J; Jiang WN; Hao JH
Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
[No Abstract] [Full Text] [Related]
31. Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.
Ohno S; Tachibana M; Fujii T; Ueda S; Kubota H; Nagasue N
Int J Cancer; 2002 Feb; 97(6):770-4. PubMed ID: 11857352
[TBL] [Abstract][Full Text] [Related]
32. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
33. CD45
Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
[TBL] [Abstract][Full Text] [Related]
34. Differential gene expression of tumor-infiltrating CD33
Toor SM; Taha RZ; Sasidharan Nair V; Saleh R; Murshed K; Abu Nada M; Elkord E
Cancer Immunol Immunother; 2021 Mar; 70(3):803-815. PubMed ID: 33000418
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
36. Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer.
Okita Y; Tanaka H; Ohira M; Muguruma K; Kubo N; Watanabe M; Fukushima W; Hirakawa K
J Surg Res; 2014 Jan; 186(1):192-200. PubMed ID: 24120241
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer.
Lee HE; Chae SW; Lee YJ; Kim MA; Lee HS; Lee BL; Kim WH
Br J Cancer; 2008 Nov; 99(10):1704-11. PubMed ID: 18941457
[TBL] [Abstract][Full Text] [Related]
38. Density of CD8-positive tumor-infiltrating T-lymphocytes is an independent prognostic factor in adenocarcinoma of the esophagogastric junction.
Knief J; Lazar-Karsten P; Wellner U; Hummel R; Thorns C
Histol Histopathol; 2019 Oct; 34(10):1121-1129. PubMed ID: 30938449
[TBL] [Abstract][Full Text] [Related]
39. Crohn's-Like Lymphoid Reaction is Associated with Oncological Prognosis and Nutritional Status in Patients with Pathological Stage II/III Gastric Cancer.
Omura Y; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Kusunoki K; Kusunoki Y; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Kusunoki M
Ann Surg Oncol; 2020 Jan; 27(1):259-267. PubMed ID: 31414294
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.
Liao Y; Ou J; Deng J; Geng P; Zeng R; Tian Y; Liang H; Ni B; Ruan Z
Med Oncol; 2013 Dec; 30(4):727. PubMed ID: 24026663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
